| Literature DB >> 30258976 |
Camila Vieira Ligo Teixeira1,2, Thiago Junqueira Ribeiro de Rezende2,3, Marina Weiler4, Thamires Naela Cardoso Magalhães1,2, Ana Flávia Mac Knight Carletti-Cassani1,2, Thiago Quinaglia Araújo Costa Silva5, Helena Passarelli Giroud Joaquim6, Leda Leme Talib6, Orestes Vicente Forlenza6, Mariana Pires Franco7, Pedro Eduardo Nechio7, Paula Teixeira Fernandes7, Fernando Cendes1,2, Marcio Luis Balthazar1,2.
Abstract
Introduction: Information about how physical exercise affects patients with amnestic mild cognitive impairment (aMCI) due to Alzheimer's disease (AD) is still missing. This study evaluated the impact of multicomponent exercise training on cognition and brain structure in aMCI subjects with cerebral spinal fluid positive AD biomarkers.Entities:
Keywords: Cognition; Cortical thickness; Hippocampus; Multicomponent exercise; aMCI due to AD
Year: 2018 PMID: 30258976 PMCID: PMC6153377 DOI: 10.1016/j.trci.2018.02.003
Source DB: PubMed Journal: Alzheimers Dement (N Y) ISSN: 2352-8737
Fig. 1The flow chart of recruitment and exclusion of participants. Abbreviations: aMCI, amnestic mild cognitive impairment; MRI, magnetic resonance imaging.
Comparison of baseline characteristics between training (T) and nontraining (NT) groups
| Characteristics | T | NT | |
|---|---|---|---|
| Gender (% female) | 60% | 61% | .94 |
| Age (y) | 69.4 (5.2) | 68.9 (5.5) | .86 |
| Education (y) | 8.3 (5.7) | 6.9 (4.2) | .25 |
| Body mass index | 26.3 (4.2) | 27.5 (3.9) | .44 |
| Medicine for, | |||
| Hypertension | 6 (30) | 6 (30) | .82 |
| Diabetes | 3 (15) | 2 (10) | .72 |
| Dyslipidemia | 4 (20) | 1 (5) | .34 |
| Depressive symptoms | 7 (35) | 6 (30) | .91 |
| Anticholinesterase | 2 (10) | 3 (3) | .72 |
| Cognitive performance | |||
| PFS score | 1.9 (3.1) | 1.8 (3.6) | .95 |
| MMSE score | 26.3 (2.1) | 25.5 (2.2) | 1.0 |
| RAVLT score | 31.0 (8.0) | 35.7 (15.6) | .10 |
| RAVLT A7 | 4.0 (2.7) | 4.9 (3.5) | .15 |
| RAVLT Rec | 5.5 (6.1) | 9.3 (4.6) | .34 |
| BDI | 6.2 (6.4) | 7.2 (9.6) | .14 |
| CSF biomarkers | |||
| Aβ1–42 (pg/mL) | 370.4 (195.6) | 355.16 (118.8) | .78 |
| Total tau (pg/mL) | 86.3 (52.3) | 74.7 (37.7) | .64 |
| p-tau (pg/mL) | 38.3 (20.3) | 43.5 (24) | .22 |
| Physical performance | |||
| IPAQ (METs/wk) | 18.6 (18.5) | 18.2 (20.8) | .72 |
| VO2max (mL/kg/min) | 19.7 (5.4) | 18.9 (3.6) | .08 |
Abbreviations: Aβ1–42, amyloid beta; BDI, Beck Depressive Inventory; CSF, cerebral spinal fluid; IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent of task; MMSE, Mini-Mental State Examination; PFS, Pfeffer Functional Scale; p-tau, tau phosphorylated; RAVLT encoding, encoding of Rey Auditory Verbal Learning Test; RAVLT A7, delayed recall of Rey Auditory Verbal Learning Test; RAVLT Rec, Rey Auditory Verbal Learning Test true recognition (i.e., recognition minus false positives); Total tau, total tau protein; VO2max, maximum oxygen intake.
NOTE. Data are presented as average (standard deviation).
Effects of intervention in aerobic fitness, neuropsychological tests, and functional activity in training (T) and nontraining (NT) groups
| T | NT | Between-group (T time 2 vs. NT time 2) | T paired | NT paired | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Variables | Time 1 | Time 2 | Time 1 | Time 2 | F | |||||
| VO2max | 19.7 (5.4) | 21.8 (6.5) | 18.9 (3.6) | 15.9 (3.9) | 15.7 | −1.7 | 7.0 | |||
| PFS | 1.9 (3.1) | 1.5 (1.7) | 1.8 (3.6) | 2.6 (2.9) | 5.7 | 0.98 | .35 | −3.19 | ||
| MMSE | 26.3 (2.1) | 24.53 (6.2) | 25.5 (2.2) | 25.95 (2.5) | 1.3 | .26 | 1.6 | .13 | 0.32 | .75 |
| RAVLT | 31.0 (8.0) | 34.6 (11.3) | 35.3 (15.0) | 34.6 (10.0) | 0.16 | .68 | −0.52 | .61 | 0.54 | .60 |
| RAVLT A7 | 4.0 (2.7) | 5.9 (5.1) | 4.9 (3.5) | 5.2 (3.6) | 4.6 | −2.4 | 0.35 | .73 | ||
| RAVLT Rec | 5.5 (6.1) | 8.6 (9.6) | 9.3 (4.6) | 5.1 (8.8) | 7.8 | −1.51 | .15 | 2.8 | ||
Abbreviations: PFS, Pfeffer Functional Scale; MMSE, Mini-Mental State Examination; RAVLT encoding, encoding of Rey Auditory Verbal Learning Test; RAVLT A7, delayed recall of Rey Auditory Verbal Learning Test; RAVLT Rec, Rey Auditory Verbal Learning Test true recognition (i.e., recognition minus false positives); VO2max, maximum oxygen intake.
NOTE. Data are presented as average ± standard deviation. P values are in bold with statistical significant (P < .05 or P < .01).
Fig. 2Differences in VO2max after 6 months in training and nontraining groups. ∗Significant interaction between-groups; †significant interaction within-groups.
Effects of intervention in cortical thickness in training (T) and nontraining (NT) groups
| T | NT | Between-group (T time 2 vs. NT time 2) uncorrected | Between-group (T time 2 vs. NT time 2) false discovery rate corrected | ||||
|---|---|---|---|---|---|---|---|
| Cortical areas | Time 1 | Time 2 | Time 1 | Time 2 | |||
| Bank of superior temporal sulcus | 2.22 (0.2) | 2.26 (0.1) | 2.21 (0.1) | 2.15 (0.1) | 6.48 | .016 | .07 |
| Caudal anterior cingulate gyrus | 2.54 (0.2) | 2.64 (0.3) | 2.64 (0.3) | 2.60 (0.3) | 4.58 | .041 | .13 |
| Entorhinal cortex | 3.14 (0.4) | 3.24 (0.3) | 3.20 (0.5) | 3.10 (0.5) | 8.92 | .006 | .06 |
| Fusiform gyrus | 2.43 (0.2) | 2.55 (0.2) | 2.52 (0.2) | 2.52 (0.2) | 7.52 | .01 | .06 |
| LH | |||||||
| Lingual gyrus | 1.78 (0.1) | 1.84 (0.1) | 1.82 (0.1) | 1.82 (0.1) | 7.25 | .011 | .31 |
| Inferior temporal gyrus | 2.48 (0.2) | 2.55 (0.2) | 2.57 (0.2) | 2.55 (0.2) | 8.14 | .008 | .39 |
| Middle temporal gyrus | 2.53 (0.2) | 2.60 (0.2) | 2.53 (0.1) | 2.53 (0.2) | 8.12 | .008 | .30 |
| Parahippocampal gyrus | 2.55 (0.3) | 2.60 (0.3) | 2.70 (0.3) | 2.66 (0.2) | 4.16 | .049 | .39 |
| Supra marginal gyrus | 2.21 (0.2) | 2.28 (0.1) | 2.24 (0.1) | 2.23 (0.1) | 8.87 | .006 | .39 |
| Temporal pole | 3.56 (0.3) | 3.67 (0.3) | 3.42 (0.3) | 3.41 (0.3) | 6.2 | .019 | .07 |
| Insula gyrus | 2.75 (0.1) | 2.8 (0.2) | 2.70 (0.2) | 2.63 (0.2) | 6.64 | .015 | .27 |
| RH | |||||||
| Isthmus cingulate gyrus | 2.31 (0.3) | 2.22 (0.2) | 2.22 (0.2) | 2.23 (0.2) | 5.11 | .031 | .35 |
| Pars orbitalis | 2.44 (0.2) | 2.48 (0.2) | 2.44 (0.2) | 2.40 (0.2) | 4.36 | .045 | .38 |
| Pars triangularis gyrus | 2.20 (0.1) | 2.23 (0.2) | 2.19 (0.1) | 2.15 (0.1) | 8.79 | .006 | .19 |
Abbreviations: CC, corpus callosum; FL, frontal lobe; FTPL, frontotemporoparietal area; LH, left hemisphere; OL, occipital lobe; PL, parietal lobe; RH, right hemisphere; TL,temporal lobe; TOL, temporal-occipital lobe.
NOTE. Data are presented as average (standard deviation).
Changes in hippocampal volume after the intervention period and comparison between groups
| T | NT | Between-group (T time 2 vs. NT time 2) | Within-group T (time 2 − time 1) | Within-group NT (time 2 − time 1) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Time 1 | Time 2 | Time 1 | Time 2 | F | ||||||
| Left hippocampal volume (mm³) | 3258.5 (687.8) | 3538.8 (416.0) | 3486.3 (635.8) | 3423.6 (665.5) | 13.7 | −2.9 | 1.04 | .31 | ||
| Right hippocampal volume (mm³) | 3369.9 (714.6) | 3663.6 (488.1) | 3584.8 (606.9) | 3544.8 (678.8) | 8.0 | −2.4 | 0.56 | .58 | ||
NOTE. Data are presented as average (standard deviation). P values are in bold with statistical significant (P < .05 or P < .01).